Randomized Controlled Trial
Copyright ©The Author(s) 2021.
World J Clin Cases. Oct 6, 2021; 9(28): 8413-8424
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8413
Table 2 Indicators of the intervention group and the control group (mean ± SD)
Indicators
IG, n = 80
CG, n = 78
Baseline
1st mo
3rd mo
6th mo
Baseline
1st mo
3rd mo
6th mo
Inflammation level
CRP (mg/L)17.74 ± 5.6515.05 ± 4.5110.83 ± 3.842.40 ± 2.0018.25 ± 5.4116.71 ± 4.4215.13 ± 3.357.93 ± 2.77
ESR (mm/h)35.61 ± 5.2931.57 ± 4.8128.03 ± 3.4223.97 ± 3.1435.36 ± 5.4132.85 ± 4.5829.81 ± 3.3628.21 ± 2.82
TNF-α (pg/mL)43.93 ± 9.0438.22 ± 8.0533.24 ± 7.9829.61 ± 6.7242.99 ± 10.1541.01 ± 9.7238.12 ± 9.1435.56 ± 8.12
Disease activity
CDAI19.97 ± 7.2920.00 ± 7.2513.90 ± 5.174.51 ± 1.9420.04 ± 8.0119.51 ± 7.9517.94 ± 6.9315.41 ± 5.26
SDAI37.71 ± 8.6735.06 ± 8.1124.73 ± 5.996.91 ± 2.4938.29 ± 8.7836.22 ± 8.2233.06 ± 7.0323.34 ± 5.24
DAS284.94 ± 1.294.56 ± 1.004.02 ± 0.783.40 ± 1.004.89 ± 1.334.94 ± 1.294.50 ± 1.254.13 ± 0.93
HAQ1.39 ± 0.641.04 ± 0.591.12 ± 0.650.36 ± 0.281.43 ± 0.701.24 ± 0.721.22 ± 0.660.91 ± 0.58
Mood disorder
SDS57.31 ± 4.7746.60 ± 5.6737.63 ± 5.1431.81 ± 9.8258.45 ± 6.1550.95 ± 6.0951.62 ± 5.7749.58 ± 6.13
SAS54.43 ± 8.3449.81 ± 7.5240.60 ± 6.3231.71 ± 8.8453.21 ± 10.9153.01 ± 10.8449.22 ± 7.3445.13 ± 9.39